marketcaparena
Search

    PFE

    PFIZER INC

    Company overview

    Market capitalization
    $163.69B
    Employees
    75,000
    Latest publication
    2026-09-29
    About PFIZER INC

    Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USDQ1 20262026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USD
    Total Revenue15,034,000,000USD14,451,000,000USD17,557,000,000USD16,654,000,000USD14,653,000,000USD13,715,000,000USD17,702,000,000USD14,879,000,000USD
    Cost Of Revenue4,092,000,000USD3,548,000,000USD5,272,000,000USD4,172,000,000USD5,233,000,000USD3,888,000,000USD6,931,000,000USD4,381,000,000USD
    Gross Profit10,942,000,000USD10,903,000,000USD12,285,000,000USD12,482,000,000USD9,420,000,000USD9,827,000,000USD10,771,000,000USD10,498,000,000USD
    Research Development2,809,000,000USD2,490,000,000USD3,418,000,000USD3,936,000,000USD2,443,000,000USD2,179,000,000USD2,565,000,000USD2,480,000,000USD
    Selling General Administrative3,411,000,000USD2,961,000,000USD4,080,000,000USD3,186,000,000USD3,415,000,000USD3,031,000,000USD3,244,000,000USD3,495,000,000USD
    Total Operating Expenses6,220,000,000USD5,451,000,000USD8,597,000,000USD8,932,000,000USD5,845,000,000USD5,203,000,000USD5,803,000,000USD5,939,000,000USD
    Operating Income4,722,000,000USD5,452,000,000USD3,688,000,000USD3,550,000,000USD3,575,000,000USD4,624,000,000USD4,968,000,000USD4,559,000,000USD
    Total Other Income Expense Net-5,375,000,000USD-2,282,000,000USD-5,330,000,000USD-216,000,000USD-531,000,000USD-1,840,000,000USD-253,000,000USD-1,138,000,000USD
    Interest Income113,000,000USD115,000,000USD517,000,000USD138,000,000USD156,000,000USD143,000,000USD116,000,000USD129,000,000USD
    Interest Expense667,000,000USD668,000,000USD711,000,000USD652,000,000USD654,000,000USD654,000,000USD783,000,000USD790,000,000USD
    Income Before Tax-653,000,000USD3,170,000,000USD-1,642,000,000USD3,334,000,000USD3,044,000,000USD2,784,000,000USD4,715,000,000USD3,421,000,000USD
    Income Tax Expense-407,000,000USD461,000,000USD-2,000,000USD-216,000,000USD141,000,000USD-189,000,000USD234,000,000USD293,000,000USD
    Discontinued Operations8,000,000USD-13,000,000USD——————
    Net Income-237,000,000USD2,696,000,000USD-1,648,000,000USD3,541,000,000USD2,910,000,000USD2,967,000,000USD4,473,000,000USD3,120,000,000USD
    Minority Interest10,000,000USD8,000,000USD-8,000,000USD-9,000,000USD-18,000,000USD-6,000,000USD-8,000,000USD-8,000,000USD
    Net Income Applicable To Common Shares-248,000,000USD2,687,000,000USD-1,648,000,000USD3,541,000,000USD2,910,000,000USD2,967,000,000USD4,465,000,000USD—
    Unclassified Operating Expenses——1,099,000,000USD1,810,000,000USD————
    Net Interest Income——-545,000,000USD-514,000,000USD-498,000,000USD-511,000,000USD-667,000,000USD-661,000,000USD
    Tax Provision——-2,000,000USD-216,000,000USD141,000,000USD-189,000,000USD234,000,000USD293,000,000USD
    Net Income From Continuing Ops——-1,640,000,000USD3,550,000,000USD2,903,000,000USD2,973,000,000USD4,481,000,000USD3,128,000,000USD
    Ebit——-931,000,000USD3,986,000,000USD3,698,000,000USD3,438,000,000USD5,498,000,000USD4,212,000,000USD
    Ebitda——756,000,000USD5,648,000,000USD5,323,000,000USD5,056,000,000USD7,253,000,000USD5,948,000,000USD
    Depreciation And Amortization——1,687,000,000USD1,662,000,000USD1,625,000,000USD1,618,000,000USD1,755,000,000USD1,736,000,000USD
    Reconciled Depreciation——1,687,000,000USD1,662,000,000USD1,625,000,000USD1,618,000,000USD1,755,000,000USD1,736,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USD
    Total Revenue29,484,000,000USD
    Cost Of Revenue7,640,000,000USD
    Gross Profit21,844,000,000USD
    Research Development5,299,000,000USD
    Selling General Administrative6,372,000,000USD
    Total Operating Expenses11,671,000,000USD
    Operating Income10,173,000,000USD
    Total Other Income Expense Net-7,656,000,000USD
    Interest Income228,000,000USD
    Interest Expense1,336,000,000USD
    Income Before Tax2,517,000,000USD
    Income Tax Expense54,000,000USD
    Discontinued Operations-5,000,000USD
    Net Income2,458,000,000USD
    Minority Interest19,000,000USD
    Net Income Applicable To Common Shares2,440,000,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue62,579,000,000USD63,627,000,000USD100,330,000,000USD81,288,000,000USD53,647,000,000USD52,546,000,000USD52,824,000,000USD48,851,000,000USD
    Cost Of Revenue16,067,000,000USD21,781,000,000USD38,240,000,000USD34,413,000,000USD16,008,000,000USD15,777,000,000USD15,954,000,000USD13,157,000,000USD
    Gross Profit46,512,000,000USD41,846,000,000USD62,090,000,000USD46,875,000,000USD37,639,000,000USD36,769,000,000USD36,870,000,000USD35,694,000,000USD
    Research Development10,437,000,000USD10,738,000,000USD11,426,000,000USD13,828,000,000USD7,967,000,000USD7,645,000,000USD7,840,000,000USD7,671,000,000USD
    Selling General Administrative13,794,000,000USD11,471,000,000USD10,877,000,000USD10,703,000,000USD11,755,000,000USD11,684,000,000USD11,637,000,000USD11,709,000,000USD
    Total Operating Expenses24,231,000,000USD25,363,000,000USD24,541,000,000USD26,082,000,000USD22,350,000,000USD22,378,000,000USD22,596,000,000USD22,398,000,000USD
    Operating Income22,281,000,000USD16,483,000,000USD37,549,000,000USD20,793,000,000USD15,289,000,000USD14,391,000,000USD14,274,000,000USD13,296,000,000USD
    Total Other Income Expense Net-14,761,000,000USD-8,460,000,000USD-2,820,000,000USD3,518,000,000USD-3,404,000,000USD-2,086,000,000USD-5,923,000,000USD-4,331,000,000USD
    Interest Income603,000,000USD545,000,000USD1,824,000,000USD560,000,000USD333,000,000USD391,000,000USD470,000,000USD1,597,000,000USD
    Interest Expense2,671,000,000USD3,091,000,000USD1,238,000,000USD1,291,000,000USD1,316,000,000USD1,270,000,000USD1,186,000,000USD1,199,000,000USD
    Income Before Tax7,520,000,000USD8,023,000,000USD34,729,000,000USD24,311,000,000USD11,885,000,000USD12,305,000,000USD8,351,000,000USD8,965,000,000USD
    Income Tax Expense-266,000,000USD-28,000,000USD3,328,000,000USD1,852,000,000USD706,000,000USD-9,048,000,000USD1,122,000,000USD1,990,000,000USD
    Discontinued Operations25,000,000USD—6,000,000USD-434,000,000USD10,000,000USD2,000,000USD17,000,000USD11,000,000USD
    Net Income7,812,000,000USD8,020,000,000USD31,365,000,000USD22,147,000,000USD11,153,000,000USD21,305,000,000USD7,215,000,000USD6,966,000,000USD
    Minority Interest41,000,000USD-31,000,000USD-35,000,000USD-45,000,000USD36,000,000USD47,000,000USD31,000,000USD26,000,000USD
    Net Income Applicable To Common Shares7,771,000,000USD8,031,000,000USD31,372,000,000USD21,979,000,000USD11,153,000,000USD21,308,000,000USD7,215,000,000USD6,960,000,000USD
    Selling And Marketing Expenses—3,300,000,000USD——2,700,000,000USD3,100,000,000USD3,200,000,000USD3,100,000,000USD
    Net Interest Income—-2,546,000,000USD-987,000,000USD-1,255,000,000USD-983,000,000USD-879,000,000USD-716,000,000USD—
    Tax Provision—-28,000,000USD3,328,000,000USD1,852,000,000USD706,000,000USD-9,049,000,000USD1,123,000,000USD1,990,000,000USD
    Net Income From Continuing Ops—8,051,000,000USD31,401,000,000USD22,459,000,000USD11,179,000,000USD21,353,000,000USD7,229,000,000USD6,975,000,000USD
    Ebit—11,114,000,000USD35,967,000,000USD25,602,000,000USD13,201,000,000USD13,575,000,000USD9,537,000,000USD10,164,000,000USD
    Ebitda—18,127,000,000USD41,031,000,000USD30,793,000,000USD19,585,000,000USD19,844,000,000USD15,294,000,000USD15,321,000,000USD
    Depreciation And Amortization—7,013,000,000USD5,064,000,000USD5,191,000,000USD6,384,000,000USD6,269,000,000USD5,757,000,000USD5,157,000,000USD
    Reconciled Depreciation—7,013,000,000USD3,609,000,000USD3,700,000,000USD6,384,000,000USD6,269,000,000USD——
    Unclassified Operating Expenses——2,238,000,000USD1,551,000,000USD————
    Non Operating Income Net Other——-217,000,000USD4,878,000,000USD-2,116,000,000USD-1,315,000,000USD-3,655,000,000USD-2,860,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USDQ1 20262026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets201,131,000,000USD207,618,000,000USD208,160,000,000USD208,731,000,000USD206,095,000,000USD208,028,000,000USD213,396,000,000USD219,476,000,000USD
    Cash And Equivalents976,000,000USD1,703,000,000USD1,142,000,000USD1,343,000,000USD1,638,000,000USD1,430,000,000USD1,043,000,000USD1,092,000,000USD
    Cash And Short Term Investments11,699,000,000USD3,568,000,000USD3,738,000,000USD14,984,000,000USD13,249,000,000USD17,316,000,000USD20,477,000,000USD9,952,000,000USD
    Short Term Investments10,723,000,000USD1,865,000,000USD2,596,000,000USD13,641,000,000USD11,611,000,000USD15,886,000,000USD19,434,000,000USD8,860,000,000USD
    Long Term Investments1,559,000,000USD1,626,000,000USD1,621,000,000USD2,138,000,000USD2,120,000,000USD2,014,000,000USD2,227,000,000USD10,762,000,000USD
    Total Current Assets41,358,000,000USD42,822,000,000USD42,898,000,000USD46,924,000,000USD43,703,000,000USD45,861,000,000USD50,358,000,000USD43,223,000,000USD
    Other Current Assets3,522,000,000USD2,908,000,000USD2,808,000,000USD2,357,000,000USD2,691,000,000USD2,948,000,000USD4,253,000,000USD3,856,000,000USD
    Other Non Current Assets9,939,000,000USD9,834,000,000USD9,631,000,000USD—————
    Total Liabilities115,639,000,000USD117,214,000,000USD121,385,000,000USD—————
    Total Current Liabilities32,646,000,000USD34,348,000,000USD36,984,000,000USD36,596,000,000USD37,726,000,000USD36,452,000,000USD42,995,000,000USD43,211,000,000USD
    Other Current Liabilities19,709,000,000USD20,108,000,000USD18,648,000,000USD—————
    Other Non Current Liabilities14,780,000,000USD14,200,000,000USD14,725,000,000USD—————
    Total Stockholder Equity85,190,000,000USD90,101,000,000USD86,476,000,000USD92,801,000,000USD88,695,000,000USD90,338,000,000USD88,203,000,000USD92,286,000,000USD
    Total Equity Including Noncontrolling Interest85,492,000,000USD90,404,000,000USD86,775,000,000USD—————
    Short Long Term Debt2,605,000,000USD3,861,000,000USD2,997,000,000USD4,303,000,000USD4,296,000,000USD4,471,000,000USD6,946,000,000USD9,699,000,000USD
    Long Term Debt60,495,000,000USD60,565,000,000USD61,641,000,000USD56,545,000,000USD56,630,000,000USD56,820,000,000USD56,703,000,000USD56,918,000,000USD
    Net Receivables12,490,000,000USD12,585,000,000USD11,874,000,000USD18,115,000,000USD16,094,000,000USD14,745,000,000USD14,777,000,000USD17,694,000,000USD
    Inventory9,945,000,000USD10,667,000,000USD10,654,000,000USD11,468,000,000USD11,669,000,000USD10,852,000,000USD10,851,000,000USD11,721,000,000USD
    Property Plant Equipment Net19,029,000,000USD19,402,000,000USD21,530,000,000USD18,880,000,000USD18,776,000,000USD18,347,000,000USD18,393,000,000USD18,541,000,000USD
    Goodwill71,419,000,000USD71,409,000,000USD71,264,000,000USD—————
    Intangible Assets47,053,000,000USD52,559,000,000USD53,731,000,000USD51,324,000,000USD52,702,000,000USD53,974,000,000USD55,412,000,000USD59,986,000,000USD
    Accounts Payable4,581,000,000USD4,506,000,000USD5,240,000,000USD5,024,000,000USD5,166,000,000USD5,240,000,000USD5,633,000,000USD5,314,000,000USD
    Short Term Debt2,699,000,000USD3,890,000,000USD3,154,000,000USD4,303,000,000USD4,295,000,000USD4,471,000,000USD6,946,000,000USD9,699,000,000USD
    Common Stock482,000,000USD482,000,000USD481,000,000USD481,000,000USD481,000,000USD481,000,000USD480,000,000USD480,000,000USD
    Retained Earnings112,087,000,000USD117,238,000,000USD114,610,000,000USD121,150,000,000USD117,609,000,000USD119,590,000,000USD116,725,000,000USD121,059,000,000USD
    Accumulated Other Comprehensive Income-7,218,000,000USD-7,203,000,000USD-8,069,000,000USD-8,067,000,000USD-8,438,000,000USD-8,581,000,000USD-7,842,000,000USD-7,971,000,000USD
    Deferred Revenue——784,000,000USD—————
    Total Liab———115,635,000,000USD117,083,000,000USD117,391,000,000USD124,899,000,000USD126,918,000,000USD
    Other Current Liab———22,546,000,000USD23,467,000,000USD25,729,000,000USD25,995,000,000USD23,301,000,000USD
    Capital Stock———481,000,000USD481,000,000USD481,000,000USD480,000,000USD480,000,000USD
    Good Will———69,101,000,000USD68,997,000,000USD68,444,000,000USD68,527,000,000USD68,570,000,000USD
    Other Assets———20,365,000,000USD19,797,000,000USD1,000,000USD40,405,000,000USD-1,000,000USD
    Cash———1,343,000,000USD1,638,000,000USD1,430,000,000USD1,043,000,000USD1,092,000,000USD
    Current Deferred Revenue———924,000,000USD1,123,000,000USD1,012,000,000USD1,511,000,000USD2,020,000,000USD
    Net Debt———60,369,000,000USD60,159,000,000USD59,861,000,000USD62,606,000,000USD65,525,000,000USD
    Short Long Term Debt Total———61,712,000,000USD61,797,000,000USD61,291,000,000USD63,649,000,000USD66,617,000,000USD
    Property Plant Equipment Gross———36,385,000,000USD36,044,000,000USD35,189,000,000USD34,876,000,000USD35,216,000,000USD
    Common Stock Shares Outstanding———5,714,000,000shares5,706,000,000shares5,710,000,000shares5,703,000,000shares5,705,000,000shares
    Non Current Assets Total———161,807,000,000USD162,392,000,000USD162,166,000,000USD163,038,000,000USD176,254,000,000USD
    Non Current Liabilities Total———79,039,000,000USD79,357,000,000USD80,939,000,000USD81,904,000,000USD83,707,000,000USD
    Non Current Liabilities Other———13,605,000,000USD13,931,000,000USD13,296,000,000USD14,151,000,000USD15,570,000,000USD
    Non Currrent Assets Other———9,317,000,000USD11,350,000,000USD9,845,000,000USD9,817,000,000USD10,486,000,000USD
    Net Working Capital———10,328,000,000USD5,977,000,000USD9,409,000,000USD7,363,000,000USD12,000,000USD
    Unclassified Non Current Assets———-9,318,000,000USD-11,350,000,000USD9,541,000,000USD-31,743,000,000USD7,909,000,000USD
    Unclassified Current Liabilities———-504,000,000USD-621,000,000USD-4,471,000,000USD-4,036,000,000USD-6,822,000,000USD
    Unclassified Non Current Liabilities———8,889,000,000USD8,796,000,000USD10,823,000,000USD11,050,000,000USD11,219,000,000USD
    Unclassified Equity———-21,244,000,000USD-21,438,000,000USD-21,633,000,000USD-21,640,000,000USD-21,762,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets208,160,000,000USD213,396,000,000USD226,501,000,000USD197,206,000,000USD181,477,000,000USD154,229,000,000USD167,488,000,000USD159,422,000,000USD
    Cash And Equivalents1,142,000,000USD1,043,000,000USD2,853,000,000USD416,000,000USD1,944,000,000USD1,784,000,000USD1,121,000,000USD1,139,000,000USD
    Cash And Short Term Investments3,738,000,000USD20,477,000,000USD12,690,000,000USD22,732,000,000USD31,069,000,000USD12,221,000,000USD9,830,000,000USD18,833,000,000USD
    Short Term Investments2,596,000,000USD19,434,000,000USD9,837,000,000USD22,316,000,000USD29,125,000,000USD10,437,000,000USD8,525,000,000USD17,694,000,000USD
    Long Term Investments1,621,000,000USD2,227,000,000USD15,368,000,000USD15,069,000,000USD21,526,000,000USD20,262,000,000USD20,147,000,000USD2,767,000,000USD
    Total Current Assets42,898,000,000USD50,358,000,000USD43,333,000,000USD51,259,000,000USD59,693,000,000USD35,067,000,000USD32,803,000,000USD49,926,000,000USD
    Other Current Assets2,808,000,000USD4,253,000,000USD9,277,000,000USD5,017,000,000USD3,820,000,000USD3,439,000,000USD2,601,000,000USD2,461,000,000USD
    Other Non Current Assets9,631,000,000USD———————
    Total Liabilities121,385,000,000USD———————
    Total Current Liabilities36,984,000,000USD42,995,000,000USD47,794,000,000USD42,138,000,000USD42,671,000,000USD25,920,000,000USD37,304,000,000USD31,858,000,000USD
    Other Current Liabilities18,648,000,000USD———————
    Other Non Current Liabilities14,725,000,000USD———————
    Total Stockholder Equity86,476,000,000USD88,203,000,000USD89,288,000,000USD95,917,000,000USD77,463,000,000USD63,473,000,000USD63,446,000,000USD63,758,000,000USD
    Total Equity Including Noncontrolling Interest86,775,000,000USD———————
    Short Long Term Debt2,997,000,000USD6,946,000,000USD10,346,000,000USD2,945,000,000USD2,241,000,000USD2,703,000,000USD16,195,000,000USD8,831,000,000USD
    Long Term Debt61,641,000,000USD56,703,000,000USD60,499,000,000USD32,884,000,000USD36,195,000,000USD37,133,000,000USD35,955,000,000USD32,909,000,000USD
    Deferred Revenue784,000,000USD———————
    Net Receivables11,874,000,000USD14,777,000,000USD11,177,000,000USD14,529,000,000USD15,745,000,000USD11,194,000,000USD12,068,000,000USD11,399,000,000USD
    Inventory10,654,000,000USD10,851,000,000USD10,189,000,000USD8,981,000,000USD9,059,000,000USD8,046,000,000USD8,283,000,000USD7,508,000,000USD
    Property Plant Equipment Net21,530,000,000USD18,393,000,000USD18,940,000,000USD16,274,000,000USD14,882,000,000USD13,900,000,000USD13,967,000,000USD13,385,000,000USD
    Goodwill71,264,000,000USD———————
    Intangible Assets53,731,000,000USD55,412,000,000USD64,900,000,000USD43,370,000,000USD25,146,000,000USD28,472,000,000USD35,369,000,000USD35,211,000,000USD
    Accounts Payable5,240,000,000USD5,633,000,000USD6,710,000,000USD6,809,000,000USD5,578,000,000USD4,309,000,000USD4,220,000,000USD4,674,000,000USD
    Short Term Debt3,154,000,000USD7,302,000,000USD10,877,000,000USD2,945,000,000USD2,241,000,000USD2,703,000,000USD16,190,000,000USD8,836,000,000USD
    Common Stock481,000,000USD480,000,000USD478,000,000USD476,000,000USD473,000,000USD470,000,000USD468,000,000USD467,000,000USD
    Retained Earnings114,610,000,000USD116,725,000,000USD118,353,000,000USD125,656,000,000USD103,394,000,000USD96,770,000,000USD97,670,000,000USD89,554,000,000USD
    Accumulated Other Comprehensive Income-8,069,000,000USD-7,842,000,000USD-7,961,000,000USD-8,304,000,000USD-5,897,000,000USD-11,688,000,000USD-11,640,000,000USD-11,275,000,000USD
    Total Liab—124,899,000,000USD137,213,000,000USD101,289,000,000USD104,014,000,000USD90,756,000,000USD104,042,000,000USD95,664,000,000USD
    Other Current Liab—28,549,000,000USD27,507,000,000USD29,864,000,000USD31,785,000,000USD12,639,000,000USD11,090,000,000USD12,639,000,000USD
    Capital Stock—480,000,000USD478,000,000USD476,000,000USD473,000,000USD470,000,000USD468,000,000USD467,000,000USD
    Good Will—68,527,000,000USD67,783,000,000USD51,375,000,000USD49,208,000,000USD49,577,000,000USD58,653,000,000USD53,411,000,000USD
    Other Assets—16,191,000,000USD6,710,000,000USD6,809,000,000USD5,578,000,000USD4,283,000,000USD4,220,000,000USD4,674,000,000USD
    Cash—1,043,000,000USD2,853,000,000USD416,000,000USD1,944,000,000USD1,784,000,000USD1,305,000,000USD1,139,000,000USD
    Current Deferred Revenue—1,511,000,000USD2,700,000,000USD2,520,000,000USD3,067,000,000USD6,269,000,000USD5,804,000,000USD5,709,000,000USD
    Net Debt—65,950,000,000USD72,188,000,000USD34,454,000,000USD35,054,000,000USD36,490,000,000USD50,840,000,000USD40,126,000,000USD
    Short Long Term Debt Total—66,993,000,000USD75,041,000,000USD35,829,000,000USD38,436,000,000USD39,836,000,000USD52,145,000,000USD41,745,000,000USD
    Property Plant Equipment Gross—34,876,000,000USD34,985,000,000USD31,448,000,000USD29,955,000,000USD28,406,000,000USD13,967,000,000USD13,385,000,000USD
    Common Stock Shares Outstanding—5,700,000,000shares5,709,000,000shares5,733,000,000shares5,708,000,000shares5,632,000,000shares5,675,000,000shares5,977,000,000shares
    Non Current Assets Total—163,038,000,000USD183,168,000,000USD145,944,000,000USD121,782,000,000USD119,163,000,000USD134,685,000,000USD109,497,000,000USD
    Non Current Liabilities Total—81,904,000,000USD89,419,000,000USD59,151,000,000USD61,343,000,000USD64,836,000,000USD66,738,000,000USD63,806,000,000USD
    Non Current Liabilities Other—14,151,000,000USD16,540,000,000USD25,242,000,000USD9,744,000,000USD23,640,000,000USD25,205,000,000USD27,197,000,000USD
    Non Currrent Assets Other—9,817,000,000USD9,145,000,000USD13,163,000,000USD7,679,000,000USD4,569,000,000USD4,450,000,000USD2,799,000,000USD
    Net Working Capital—7,363,000,000USD-4,461,000,000USD9,121,000,000USD17,022,000,000USD9,147,000,000USD-4,501,000,000USD18,068,000,000USD
    Unclassified Non Current Assets—-7,529,000,000USD——-2,237,000,000USD-1,900,000,000USD-2,121,000,000USD-2,750,000,000USD
    Unclassified Current Liabilities—-6,946,000,000USD-10,346,000,000USD-2,945,000,000USD-2,241,000,000USD-2,703,000,000USD-16,195,000,000USD-8,831,000,000USD
    Unclassified Non Current Liabilities—11,050,000,000USD11,740,000,000USD-23,346,000,000USD-7,582,000,000USD-26,589,000,000USD-29,736,000,000USD-30,519,000,000USD
    Unclassified Equity—-21,640,000,000USD——————
    Deferred Long Term Liab——640,000,000USD1,023,000,000USD349,000,000USD4,063,000,000USD5,578,000,000USD3,700,000,000USD
    Additional Paid In Capital——92,631,000,000USD91,802,000,000USD90,591,000,000USD88,674,000,000USD87,428,000,000USD86,253,000,000USD
    Treasury Stock——-114,487,000,000USD-113,969,000,000USD-111,361,000,000USD-110,988,000,000USD-110,801,000,000USD-101,610,000,000USD
    Net Tangible Assets——89,014,000,000USD95,661,000,000USD77,201,000,000USD63,238,000,000USD-30,896,000,000USD-25,656,000,000USD
    Other Liab———23,348,000,000USD22,637,000,000USD26,589,000,000USD29,736,000,000USD30,519,000,000USD
    Unclassified Current Assets———————9,725,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USD
    Net Income2,463,000,000USD
    Depreciation3,235,000,000USD
    Stock Based Compensation521,000,000USD
    Deferred Income Tax-1,332,000,000USD
    Other Non Cash Items2,111,000,000USD
    Change In Working Capital-3,548,000,000USD
    Operating Cash Flow3,450,000,000USD
    Capital Expenditures-969,000,000USD
    Net Investments1,964,000,000USD
    Other Investing Activities1,896,000,000USD
    Investing Cash Flow2,891,000,000USD
    Net Debt Issuance-1,313,000,000USD
    Common Dividends Paid-4,896,000,000USD
    Other Financing Activities-311,000,000USD
    Unclassified Financing Cash Flow1,000,000USD
    Financing Cash Flow-6,519,000,000USD
    Effect Of Forex Changes On Cash15,000,000USD
    Change In Cash-164,000,000USD
    End Cash Flow1,034,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation1,613,000,000USD1,687,000,000USD1,662,000,000USD1,625,000,000USD1,618,000,000USD1,791,000,000USD1,755,000,000USD1,731,000,000USD
    Stock Based Compensation272,000,000USD225,000,000USD201,000,000USD203,000,000USD170,000,000USD177,000,000USD274,000,000USD206,000,000USD
    Deferred Income Tax-12,000,000USD———————
    Other Non Cash Items93,000,000USD4,153,000,000USD-10,000,000USD-6,985,000,000USD156,000,000USD1,812,000,000USD-193,000,000USD569,000,000USD
    Operating Cash Flow2,615,000,000USD———————
    Capital Expenditures-436,000,000USD-845,000,000USD-602,000,000USD-618,000,000USD-564,000,000USD-917,000,000USD-651,000,000USD-637,000,000USD
    Net Investments-104,000,000USD———————
    Other Investing Activities-22,000,000USD———————
    Unclassified Investing Cash Flow1,347,000,000USD-6,927,000,000USD590,000,000USD627,000,000USD265,000,000USD905,000,000USD645,000,000USD656,000,000USD
    Investing Cash Flow785,000,000USD———————
    Net Debt Issuance-127,000,000USD———————
    Other Financing Activities-284,000,000USD———————
    Unclassified Financing Cash Flow-2,445,000,000USD———————
    Financing Cash Flow-2,856,000,000USD———————
    Effect Of Forex Changes On Cash19,000,000USD———————
    Change In Cash563,000,000USD-201,000,000USD-300,000,000USD213,000,000USD374,000,000USD-45,000,000USD40,000,000USD343,000,000USD
    End Cash Flow1,760,000,000USD———————
    Net Income—-1,648,000,000USD3,551,000,000USD2,928,000,000USD2,973,000,000USD411,000,000USD4,481,000,000USD31,000,000USD
    Change In Working Capital—1,590,000,000USD-36,000,000USD1,919,000,000USD-1,919,000,000USD2,926,000,000USD879,000,000USD-3,535,000,000USD
    Total Cash From Operating Activities—5,349,000,000USD4,603,000,000USD-582,000,000USD2,335,000,000USD6,721,000,000USD6,714,000,000USD-1,781,000,000USD
    Free Cash Flow—4,504,000,000USD4,001,000,000USD-1,200,000,000USD1,771,000,000USD5,804,000,000USD6,063,000,000USD-2,418,000,000USD
    Investments—1,763,000,000USD-2,430,000,000USD3,951,000,000USD3,274,000,000USD-1,623,000,000USD-2,057,000,000USD4,600,000,000USD
    Total Cashflows From Investing Activities—-6,146,000,000USD-2,430,000,000USD3,951,000,000USD3,274,000,000USD-1,623,000,000USD-2,057,000,000USD4,600,000,000USD
    Net Borrowings—3,085,000,000USD6,000,000USD-731,000,000USD-2,434,000,000USD-2,720,000,000USD-2,250,000,000USD—
    Total Cash From Financing Activities—596,000,000USD-2,476,000,000USD-3,196,000,000USD-5,227,000,000USD-5,114,000,000USD-4,636,000,000USD-2,459,000,000USD
    Dividends Paid—-2,445,000,000USD-2,444,000,000USD-2,445,000,000USD-2,437,000,000USD-2,380,000,000USD-2,380,000,000USD-2,380,000,000USD
    Begin Period Cash Flow—1,343,000,000USD1,694,000,000USD1,481,000,000USD1,107,000,000USD1,152,000,000USD1,052,000,000USD780,000,000USD
    End Period Cash Flow—1,142,000,000USD1,394,000,000USD1,694,000,000USD1,481,000,000USD1,107,000,000USD1,092,000,000USD1,123,000,000USD
    Other Cashflows From Investing Activities—-137,000,000USD12,000,000USD-9,000,000USD299,000,000USD12,000,000USD6,000,000USD-19,000,000USD
    Other Cashflows From Financing Activities—-44,000,000USD-38,000,000USD-20,000,000USD-356,000,000USD-14,000,000USD-6,000,000USD-63,000,000USD
    Unclassified Operating Cash Flow—-658,000,000USD-765,000,000USD-272,000,000USD-663,000,000USD-396,000,000USD-482,000,000USD-783,000,000USD
    Sale Purchase Of Stock—————0USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Depreciation6,592,000,000USD7,013,000,000USD6,290,000,000USD5,064,000,000USD4,777,000,000USD6,010,000,000USD6,384,000,000USD6,269,000,000USD
    Stock Based Compensation799,000,000USD877,000,000USD525,000,000USD872,000,000USD756,000,000USD718,000,000USD949,000,000USD840,000,000USD
    Deferred Income Tax-2,133,000,000USD———————
    Other Non Cash Items470,000,000USD1,971,000,000USD5,327,000,000USD150,000,000USD3,592,000,000USD-7,025,000,000USD437,000,000USD-10,880,000,000USD
    Change To Account Receivables-263,000,000USD-109,000,000USD347,000,000USD261,000,000USD-1,249,000,000USD-742,000,000USD-644,000,000USD259,000,000USD
    Change To Inventory561,000,000USD-854,000,000USD6,199,000,000USD592,000,000USD-736,000,000USD-1,050,000,000USD-717,000,000USD-357,000,000USD
    Change To Liabilities-3,667,000,000USD——-803,000,000USD1,856,000,000USD-3,034,000,000USD451,000,000USD1,425,000,000USD
    Change In Working Capital-2,080,000,000USD-3,066,000,000USD-2,172,000,000USD-4,456,000,000USD-275,000,000USD-4,031,000,000USD-926,000,000USD1,296,000,000USD
    Operating Cash Flow11,704,000,000USD———————
    Capital Expenditures-2,629,000,000USD-2,909,000,000USD-3,907,000,000USD-3,236,000,000USD-2,791,000,000USD-2,594,000,000USD-2,196,000,000USD-2,217,000,000USD
    Net Investments-294,000,000USD———————
    Other Investing Activities-7,092,000,000USD———————
    Unclassified Investing Cash Flow8,664,000,000USD-2,652,000,000USD4,087,000,000USD-11,125,000,000USD539,000,000USD419,000,000USD154,000,000USD-1,000,000,000USD
    Investing Cash Flow-1,351,000,000USD———————
    Net Debt Issuance-74,000,000USD———————
    Other Financing Activities-458,000,000USD———————
    Unclassified Financing Cash Flow-9,772,000,000USD——-3,891,000,000USD-17,999,000,000USD394,000,000USD—379,000,000USD
    Financing Cash Flow-10,304,000,000USD———————
    Effect Of Forex Changes On Cash41,000,000USD———————
    Change In Cash91,000,000USD-1,810,000,000USD2,449,000,000USD-1,515,000,000USD475,000,000USD125,000,000USD-206,000,000USD-1,253,000,000USD
    End Cash Flow1,197,000,000USD———————
    Net Income—8,051,000,000USD2,172,000,000USD31,401,000,000USD7,021,000,000USD16,302,000,000USD11,188,000,000USD21,355,000,000USD
    Total Cash From Operating Activities—12,744,000,000USD8,700,000,000USD29,267,000,000USD14,403,000,000USD12,588,000,000USD15,827,000,000USD16,470,000,000USD
    Free Cash Flow—9,835,000,000USD4,793,000,000USD26,031,000,000USD11,612,000,000USD9,994,000,000USD13,631,000,000USD14,253,000,000USD
    Investments—2,652,000,000USD-32,278,000,000USD11,125,000,000USD-2,592,000,000USD9,304,000,000USD6,434,000,000USD-2,174,000,000USD
    Total Cashflows From Investing Activities—2,652,000,000USD-32,278,000,000USD-15,783,000,000USD-4,271,000,000USD-3,945,000,000USD4,525,000,000USD-4,741,000,000USD
    Net Borrowings—-7,159,000,000USD35,945,000,000USD-3,516,000,000USD-12,755,000,000USD8,764,000,000USD-935,000,000USD-1,005,000,000USD
    Total Cash From Financing Activities—-17,140,000,000USD26,066,000,000USD-14,834,000,000USD-9,649,000,000USD-8,485,000,000USD-20,441,000,000USD-13,035,000,000USD
    Dividends Paid—-9,512,000,000USD-9,247,000,000USD-8,983,000,000USD-8,440,000,000USD-8,043,000,000USD-7,978,000,000USD-7,659,000,000USD
    Sale Purchase Of Stock—0USD0USD-2,000,000,000USD425,000,000USD-8,865,000,000USD-12,198,000,000USD-5,000,000,000USD
    Begin Period Cash Flow—2,917,000,000USD468,000,000USD1,983,000,000USD1,350,000,000USD1,225,000,000USD1,431,000,000USD2,595,000,000USD
    End Period Cash Flow—1,107,000,000USD2,917,000,000USD468,000,000USD1,825,000,000USD1,350,000,000USD1,225,000,000USD1,342,000,000USD
    Other Cashflows From Investing Activities—5,561,000,000USD-180,000,000USD-12,547,000,000USD573,000,000USD-11,074,000,000USD133,000,000USD650,000,000USD
    Other Cashflows From Financing Activities—-469,000,000USD-632,000,000USD3,556,000,000USD29,120,000,000USD-735,000,000USD670,000,000USD250,000,000USD
    Unclassified Operating Cash Flow—-2,102,000,000USD-3,442,000,000USD-3,764,000,000USD-1,468,000,000USD614,000,000USD-2,205,000,000USD-2,410,000,000USD
    Cash And Cash Equivalents Changes———-1,350,000,000USD483,000,000USD158,000,000USD-89,000,000USD-1,254,000,000USD
    Exchange Rate Changes———————53,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Comirnaty Remaining Performance Obligations

    Period endPeriodValueUnitSource
    2026-06-28instant2,000,000,000USDDisclosure

    Paxlovid Remaining Performance Obligations

    Period endPeriodValueUnitSource
    2026-06-28instant965,000,000USDDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-28GeographyInternational Developed Markets3,743,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-28GeographyInternational Emerging Markets2,434,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-28GeographyUnited States8,857,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-28ProductOther2,697,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-28ProductProduct11,863,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-28ProductRoyalty474,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29GeographyInternational Developed Markets3,426,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29GeographyInternational Emerging Markets2,293,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29GeographyUnited States8,731,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29ProductOther2,340,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29ProductProduct11,715,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-29ProductRoyalty396,000,000USDDisclosure
    Q4 2025Quarterly · 2025-12-31GeographyInternational Developed Markets5,921,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyInternational Emerging Markets2,517,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States9,119,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOther2,582,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct14,495,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductRoyalty480,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational Developed Markets16,188,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31GeographyInternational Emerging Markets9,313,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31GeographyUnited States37,078,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductOther9,266,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductProduct51,663,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductRoyalty1,650,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30GeographyInternational Developed Markets3,696,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30GeographyInternational Emerging Markets2,267,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30GeographyUnited States10,691,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductOther2,298,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductProduct13,920,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductRoyalty436,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30GeographyInternational Developed Markets3,393,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30GeographyInternational Emerging Markets2,366,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30GeographyUnited States8,894,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductOther2,273,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductProduct11,954,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductRoyalty426,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31GeographyInternational Developed Markets6,283,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31GeographyInternational Emerging Markets2,259,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31GeographyUnited States9,221,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductOther2,247,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductProduct15,085,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductRoyalty431,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31GeographyInternational Developed Markets16,057,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31GeographyInternational Emerging Markets8,879,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31GeographyUnited States38,691,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductOther8,388,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductProduct53,816,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductRoyalty1,423,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30GeographyInternational Developed Markets3,412,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30GeographyInternational Emerging Markets2,226,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30GeographyUnited States12,064,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductOther1,459,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductPaxlovid NDALabeled USStrategic National Stockpile442,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductProduct15,417,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductRoyalty384,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentBiopharma17,392,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentPfizer Centre One285,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentPfizer Ignite25,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30GeographyInternational Developed Markets3,164,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30GeographyInternational Emerging Markets2,227,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30GeographyUnited States7,892,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductOther2,067,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductProduct10,871,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductRoyalty345,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentBiopharma12,991,000,000USD0000078003-24-000166
    Q2 2024Quarterly · 2024-06-30SegmentPfizer Centre One278,000,000USD0000078003-24-000166
    Q2 2024Quarterly · 2024-06-30SegmentPfizer Ignite15,000,000USD0000078003-24-000166
    Q1 2024Quarterly · 2024-03-31SegmentBiopharma14,604,000,000USD0000078003-24-000107
    Q1 2024Quarterly · 2024-03-31SegmentBusiness Innovation275,000,000USD0000078003-24-000107
    FY 2023Yearly · 2023-12-31GeographyInternational Developed Markets20,910,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31GeographyInternational Emerging Markets10,498,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31GeographyUnited States28,145,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductOther7,581,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductProduct50,914,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductRoyalty1,058,000,000USDDisclosure
    Q4 2023Quarterly · 2023-12-31SegmentBiopharma13,665,000,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentBusiness Innovation379,000,000USDLegacy provider
    FY 2023Yearly · 2023-12-31SegmentBiopharma57,186,000,000USD0000078003-24-000039
    FY 2023Yearly · 2023-12-31SegmentBusiness Innovation1,310,000,000USD0000078003-24-000039
    Q3 2023Quarterly · 2023-09-30SegmentBiopharma13,188,000,000USDDisclosure
    Q3 2023Quarterly · 2023-09-30SegmentPfizer Centre One293,000,000USDDisclosure
    Q3 2023Quarterly · 2023-09-30SegmentPfizer Ignite10,000,000USDDisclosure
    Q2 2023Quarterly · 2023-06-30SegmentBiopharma12,690,000,000USD0000078003-24-000166
    Q2 2023Quarterly · 2023-06-30SegmentPfizer Centre One307,000,000USD0000078003-24-000166
    Q2 2023Quarterly · 2023-06-30SegmentPfizer Ignite10,000,000USD0000078003-24-000166
    Q1 2023Quarterly · 2023-03-31SegmentBiopharma18,173,000,000USD0000078003-24-000107
    Q1 2023Quarterly · 2023-03-31SegmentBusiness Innovation313,000,000USD0000078003-24-000107
    FY 2022Yearly · 2022-12-31GeographyDeveloped Europe21,982,000,000USD0000078003-24-000039
    FY 2022Yearly · 2022-12-31GeographyDeveloped Rest Of World15,778,000,000USD0000078003-24-000039
    FY 2022Yearly · 2022-12-31GeographyEmerging Markets20,097,000,000USD0000078003-24-000039
    FY 2022Yearly · 2022-12-31GeographyUnited States42,473,000,000USD0000078003-24-000039
    FY 2022Yearly · 2022-12-31ProductOther8,537,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31ProductProduct91,793,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31ProductRoyalty845,000,000USDDisclosure
    Q4 2022Quarterly · 2022-12-31SegmentBiopharma23,921,000,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentBusiness Innovation368,000,000USDLegacy provider
    FY 2022Yearly · 2022-12-31SegmentBiopharma98,988,000,000USD0000078003-24-000039
    FY 2022Yearly · 2022-12-31SegmentBusiness Innovation1,342,000,000USD0000078003-24-000039
    FY 2021Yearly · 2021-12-31GeographyDeveloped Europe18,336,000,000USD0000078003-24-000039
    FY 2021Yearly · 2021-12-31GeographyDeveloped Rest Of World12,506,000,000USD0000078003-24-000039

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.